Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Health Security
|
October 20, 2018
Federal Funding for Health Security in FY2019
Crystal Watson, Matthew Watson, Daniel Gastfriend, et al.
Journal of Medical Economics
|
November 26, 2014
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden
Ken O'Day, Kellie Meyer, Dana Stafkey-Mailey, et al.
Oncology and Therapy
|
October 14, 2020
Qualitative Findings on the Impact of Disease in Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM
Crystal Watson, Arie Barlev, Jason C Cole, et al.
Journal of Medical Economics
|
July 10, 2020
Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants
Crystal Watson, Hairong Xu, Nicole Princic, et al.
Advances in Therapy
|
August 21, 2012
Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan
Benjamin Chastek, Kathleen M Fox, Crystal Watson, et al.
Journal of Drug Assessment
|
January 25, 2021
Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients
Crystal Watson, Arie Barlev, Jodie Worrall, et al.
Health Security
|
April 17, 2026
Participatory Approaches to Risk Assessment Across One Health Disciplines: A Scoping Review
Shalini Singaravelu, Crystal Watson, Lauren M Sauer, et al.
Clinical Therapeutics
|
October 22, 2013
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States
Machaon M Bonafede, Barbara H Johnson, Madé Wenten, et al.
Preventive Medicine Reports
|
December 30, 2025
Personal protective equipment stockpile practices: a document and scoping review
Caitlin Walker, Eric Toner, Erin Sorrell, et al.
Neurology and Therapy
|
March 10, 2022
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments
Crystal Watson, Kayla Scippa, Arie Barlev, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Health Security
|
October 20, 2018
Federal Funding for Health Security in FY2019
Crystal Watson, Matthew Watson, Daniel Gastfriend, et al.
Journal of Medical Economics
|
November 26, 2014
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden
Ken O'Day, Kellie Meyer, Dana Stafkey-Mailey, et al.
Oncology and Therapy
|
October 14, 2020
Qualitative Findings on the Impact of Disease in Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM
Crystal Watson, Arie Barlev, Jason C Cole, et al.
Journal of Medical Economics
|
July 10, 2020
Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants
Crystal Watson, Hairong Xu, Nicole Princic, et al.
Advances in Therapy
|
August 21, 2012
Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan
Benjamin Chastek, Kathleen M Fox, Crystal Watson, et al.
Journal of Drug Assessment
|
January 25, 2021
Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients
Crystal Watson, Arie Barlev, Jodie Worrall, et al.
Health Security
|
April 17, 2026
Participatory Approaches to Risk Assessment Across One Health Disciplines: A Scoping Review
Shalini Singaravelu, Crystal Watson, Lauren M Sauer, et al.
Clinical Therapeutics
|
October 22, 2013
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States
Machaon M Bonafede, Barbara H Johnson, Madé Wenten, et al.
Preventive Medicine Reports
|
December 30, 2025
Personal protective equipment stockpile practices: a document and scoping review
Caitlin Walker, Eric Toner, Erin Sorrell, et al.
Neurology and Therapy
|
March 10, 2022
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments
Crystal Watson, Kayla Scippa, Arie Barlev, et al.
Page
of 7